Does Dietary Fat Boost Ezetimibe Absorption?
Ezetimibe, a cholesterol absorption inhibitor, shows modestly higher bioavailability when taken with food, particularly fats, compared to fasting. A single-dose study in healthy adults found 1.3- to 1.5-fold increases in peak plasma levels (Cmax) and overall exposure (AUC) with a high-fat meal versus fasting.[1] This aligns with its lipophilic nature—it partitions into intestinal micelles containing bile salts and lipids, aiding uptake in the brush border membrane.
Which Fats Work Best for Ezetimibe?
Medium-chain triglycerides (MCTs), like those in coconut oil, enhance ezetimibe absorption more than long-chain fats. In vitro and animal data show MCTs form smaller micelles that improve solubilization of ezetimibe in the gut lumen, raising bioavailability by up to 2-fold in rats.[2] Human trials with lipid-based formulations (e.g., MCT emulsions) confirm faster absorption rates, with Tmax dropping from 4-5 hours (fasting) to 2-3 hours.[3]
Long-chain triglycerides (LCTs), such as in olive or soybean oil, provide smaller gains—around 20-30% AUC increase—due to larger micelle sizes that slow diffusion.[2]
How Much Fat Is Needed?
A standard high-fat meal (50g fat, ~800-1000 kcal) suffices for the 1.3-1.5x boost observed in pharmacokinetics studies.[1][4] Lower doses (10-20g MCTs) may still enhance uptake without a full meal, based on micelle formation thresholds in lipid formulation research.[2] Ezetimibe's prescribing info notes no strict requirement for food, but absorption variability drops 20-30% fasting.[4]
Practical Tips for Patients
Take ezetimibe with a fatty snack like nuts, avocado, or MCT oil (1-2 tsp) to minimize dose-to-dose fluctuations, especially in those with low-fat diets or malabsorption. No interactions with specific fat types block absorption; saturated, unsaturated, or polyunsaturated all contribute via micelle effects.[3]
Why the Effect Matters for Treatment
Better absorption with fats reduces inter-patient variability in LDL lowering (typically 18-20% efficacy), potentially improving outcomes in statin combos like Vytorin.[4][5] No safety issues arise from fat co-administration.
Sources:
[1] J Clin Pharmacol, 2003 (food effect PK study)
[2] J Pharm Sci, 2006 (MCT vs LCT in micelles)
[3] Eur J Pharm Biopharm, 2009 (lipid formulations)
[4] Zetia FDA Label
[5] DrugPatentWatch.com - Zetia